Back

Pathogenic cardiomyopathy gene variants inform prognosis in atrial fibrillation: results from exome sequencing in over 17,000 patients in TIMI trials

30 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Genetics: new findings across the spectrum of cardiovascular disease Genetics, Epigenetics, ncRNA ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Sean Joseph Jurgens

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Does PhenoAge acceleration impact adverse outcomes following major surgery (rehospitalization or death)? A genome-wide association study and mendelian randomisation
Doctor M. Raja (Leicester, GB)
Abstract Slides
Presentation thumbnail
A Genome-Wide Association Study (GWAS) of Takotsubo syndrome
Doctor H. Hakansson (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Exome sequencing identifies a novel FBN1 variant in a Chinese family with Marfan syndrome that includes aberrant right subclavian artery
Doctor S. Huang (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Proteogenomic analysis in population biobanks identifies new therapeutic targets across heart failure subtypes
Doctor A. Henry (London, GB)
Abstract Slides
Presentation thumbnail
Reinterpretation of genetic testing for Cardiomyopathies: Less is more
Doctor V. Novelli (Milano, IT)
Abstract Slides

Access the full session

Session thumbnail
Genetics: new findings across the spectrum of cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August 2024 13:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources